News

Filter

Current filters:

PharmAthene

1 to 9 of 10 results

SIGA Technologies files for Chapter 11 reorganization

SIGA Technologies files for Chapter 11 reorganization

16-09-2014

Biological warfare defense firm SIGA Technologies has filed a voluntary petition for relief under chapter…

Anti-viralsBiotechnologyFinancialLegalPharmAtheneSIGA TechnologiesTecovirimatUSA

US court orders SIGA to pay PharmAthene lump sum expectation damages

US court orders SIGA to pay PharmAthene lump sum expectation damages

11-08-2014

USA-based biodefense company PharmAthene says that, on Friday, the Delaware Court of Chancery issued…

Anti-viralsDelaware Court of ChanceryFinancialLegalPharmaceuticalPharmAtheneSIGA TechnologiesTecovirimatUSA

PharmAthene pulls out of merger deal with Theraclone

03-12-2013

USA-based biodefense company PharmAthene has decided to terminate its previously-announced all stock…

Mergers & AcquisitionsPharmaceuticalPharmAtheneTheraclone Sciences

US HHS replenishes nation's supply of anthrax antitoxin

20-09-2013

The USA’s supply of anthrax antitoxin will be maintained until 2018 under Project BioShield contracts…

Cangene CorpElusys TherapeuticsEmergent ProductsGlaxoSmithKlineHealthcareMarkets & MarketingNorth AmericaPharmaceuticalPharmAthene

PharmAthene and Theraclone agree merger

02-08-2013

USA-based biodefense company PharmAthene (NYSE MKT: PIP) and privately-held monoclonal antibody specialist…

BiotechnologyMergers & AcquisitionsPharmAtheneTheraclone Sciences

PharmAthene gets exclusive rights to Percivia's PER.C6 cell line for recombinant bioscavenger

14-01-2013

US biomedical firm PharmAthene, Inc. (NYSE MKT: PIP) says it has entered into an exclusive commercial…

BiotechnologyLicensingPER.C6PerciviaPharmAthene

PharmAthene files legal brief in response to SIGA's motion for reargument

14-10-2011

USA-based PharmAthene (NYSE Amex: PIP) says it has filed its legal brief in response to one-time merger…

LegalNorth AmericaPharmaceuticalPharmAtheneSIGA Technologies

PharmAthene awarded 50% profit split on SIGA smallpox drug

25-09-2011

USA-based PharmAthene (NYSE Amex: PIP) last week won a significant decision in its litigation against…

Anti-viralsFinancialLegalNorth AmericaPharmaceuticalPharmAtheneSIGA Technologies

1 to 9 of 10 results

COMPANY SPOTLIGHT

Menarini

Back to top